Citation 135753

KIM,CJ: CHO,SK:. (1991). PHARMACOLOGICAL ACTIVITIES OF FLAVONOIDS (III) STRUCTURE-ACTIVITY RELATIONSHIPS OF FLAVONOIDS IN IMMUNOSUPPRESSION.. 14(2)

Citation Details

Title	PHARMACOLOGICAL ACTIVITIES OF FLAVONOIDS (III) STRUCTURE-ACTIVITY RELATIONSHIPS OF FLAVONOIDS IN IMMUNOSUPPRESSION.
Authors	KIM,CJ: CHO,SK:
Year	1991
Volume	14
Issue	2

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	FLAVONE	ACTIVE
2	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	FLAVONE	ACTIVE
3	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FLAVONE	ACTIVE
4	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FLAVONE	ACTIVE
5	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FLAVONE	ACTIVE
6	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	CHRYSIN	ACTIVE
7	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	CHRYSIN	ACTIVE
8	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CHRYSIN	WEAK ACTIVITY
9	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CHRYSIN	WEAK ACTIVITY
10	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CHRYSIN	ACTIVE
11	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	BAICALEIN	ACTIVE
12	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	BAICALEIN	ACTIVE
13	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	BAICALEIN	ACTIVE
14	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	BAICALEIN	ACTIVE
15	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	BAICALEIN	ACTIVE
16	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	APIGENIN	INACTIVE
17	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	APIGENIN	ACTIVE
18	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	APIGENIN	ACTIVE
19	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	APIGENIN	WEAK ACTIVITY
20	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	APIGENIN	ACTIVE
21	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	FISETIN	ACTIVE
22	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	FISETIN	WEAK ACTIVITY
23	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FISETIN	ACTIVE
24	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FISETIN	WEAK ACTIVITY
25	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	FISETIN	ACTIVE
26	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	WEAK ACTIVITY
27	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	ACTIVE
28	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	ACTIVE
29	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	WEAK ACTIVITY
30	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	ACTIVE
31	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MORIN	WEAK ACTIVITY
32	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	MORIN	ACTIVE
33	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MORIN	ACTIVE
34	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MORIN	ACTIVE
35	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MORIN	ACTIVE
36	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICETIN	ACTIVE
37	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICETIN	WEAK ACTIVITY
38	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICETIN	WEAK ACTIVITY
39	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICETIN	ACTIVE
40	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICETIN	ACTIVE
41	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	TAXIFOLIN	INACTIVE
42	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	TAXIFOLIN	ACTIVE
43	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TAXIFOLIN	WEAK ACTIVITY
44	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TAXIFOLIN	WEAK ACTIVITY
45	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TAXIFOLIN	ACTIVE
46	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	QUERCETIN	ACTIVE
47	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	QUERCETIN	ACTIVE
48	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	QUERCETIN	ACTIVE
49	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	QUERCETIN	ACTIVE
50	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	QUERCETIN	ACTIVE
51	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	RUTIN	INACTIVE
52	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	RUTIN	ACTIVE
53	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	RUTIN	ACTIVE
54	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	RUTIN	WEAK ACTIVITY
55	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	RUTIN	ACTIVE
56	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERETIN	ACTIVE
57	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERETIN	WEAK ACTIVITY
58	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERETIN	INACTIVE
59	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERETIN	ACTIVE
60	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERETIN	ACTIVE
61	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	NARINGIN	ACTIVE
62	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	NARINGIN	ACTIVE
63	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	NARINGIN	ACTIVE
64	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	NARINGIN	WEAK ACTIVITY
65	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	NARINGIN	ACTIVE
66	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN	ACTIVE
67	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN	ACTIVE
68	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN	ACTIVE
69	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN	ACTIVE
70	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN	ACTIVE
71	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAIDZEIN	ACTIVE
72	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAIDZEIN	ACTIVE
73	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAIDZEIN	ACTIVE
74	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAIDZEIN	ACTIVE
75	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	DAIDZEIN	ACTIVE
76	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	CYANIN	ACTIVE
77	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	CYANIN	WEAK ACTIVITY
78	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CYANIN	WEAK ACTIVITY
79	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CYANIN	WEAK ACTIVITY
80	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CYANIN	ACTIVE
81	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	MALVIN	STRONG ACTIVITY
82	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	MALVIN	WEAK ACTIVITY
83	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MALVIN	WEAK ACTIVITY
84	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MALVIN	WEAK ACTIVITY
85	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MALVIN	ACTIVE
86	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	CATECHIN,(+):	WEAK ACTIVITY
87	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	CATECHIN,(+):	EQUIVOCAL
88	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CATECHIN,(+):	WEAK ACTIVITY
89	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CATECHIN,(+):	ACTIVE
90	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	CATECHIN,(+):	ACTIVE
91	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN,NEO:	ACTIVE
92	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN,NEO:	ACTIVE
93	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN,NEO:	WEAK ACTIVITY
94	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN,NEO:	EQUIVOCAL
95	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HESPERIDIN,NEO:	WEAK ACTIVITY
96	PHAGOCYTOSIS STIMULATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTENONE	ACTIVE
97	ANTIBODY FORMATION SUPPRESSION	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTENONE	ACTIVE
98	HUMORAL IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTENONE	ACTIVE
99	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTENONE	EQUIVOCAL
100	CELLULAR IMMUNITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ROTENONE	WEAK ACTIVITY

Citation 135753

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1